December 30, 2024 - 12:23

Recent research conducted on pigs has revealed that the active ingredient found in Ozempic and Wegovy offers significant heart health benefits, extending beyond their well-known effects on weight loss. The study highlights how these medications not only aid in reducing body weight but also contribute positively to cardiovascular health.
The findings indicate that the active compound in these medications may enhance heart function and improve overall cardiovascular conditions. This dual benefit is particularly crucial as obesity is often linked to various heart-related issues, making weight management a vital aspect of maintaining heart health.
Researchers are optimistic that these results could pave the way for further studies in humans, potentially leading to new treatment protocols that prioritize both weight loss and heart health. As the medical community continues to explore the multifaceted benefits of these medications, patients and healthcare providers alike may find new opportunities to improve health outcomes related to obesity and heart disease.
February 21, 2026 - 09:17
I spent 22 years unable to burp. Here’s what happened when I finally could.For decades, a silent and often misunderstood condition governed daily life. Known informally as `no-burp syndrome,` or retrograde cricopharyngeus dysfunction (R-CPD), it leaves sufferers...
February 20, 2026 - 21:10
USF Health Morsani College of Medicine claims two national Top 10 rankings in NIH fundingThe University of South Florida Health Morsani College of Medicine has demonstrated significant research strength, earning two coveted spots in the national Top 10 for National Institutes of Health...
February 20, 2026 - 08:41
Cambridge mental health charity says £205K grant is 'pivotal'A Cambridge-based mental health charity has described a substantial new grant as `pivotal` to its future, enabling a significant expansion of its community services. The organization, Sew Positive,...
February 19, 2026 - 19:15
Svetlana Lipyanskaya, MPA, FACHE to be Appointed CEO of Maimonides Health, Pending Final Approval of Partnership with NYC Health + Hospitals - NYC Health + HospitalsNew York, NY — Svetlana Lipyanskaya, MPA, FACHE, is set to become the new Chief Executive Officer of Maimonides Health, pending final approval of a new partnership between the Brooklyn-based...